TB Alliance with the support of the Republic of Korea announce initiative to broaden adoption and scale up of new treatments for drug-resistant TB

LIFT-TB to increase treatment completion rates for drug-resistant TB, focusing on seven high-burden Southeast and Central Asian countries that shoulder about 1 in 5 TB case.

To read the full press release, click here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By TB Alliance

Published: Oct. 21, 2020, 3:18 p.m.

Last updated: Oct. 27, 2020, 3:18 p.m.

Print Share